| Date Filed | Type | Description |
| 08/24/2023 |
SC 13D/A
| Juvenescence Ltd reports a 78.6% stake in AGEX THERAPEUTICS, INC. |
| 03/22/2023 |
SC 13D/A
| Juvenescence Ltd reports a 78.7% stake in AGEX THERAPEUTICS, INC. |
| 01/27/2023 |
SC 13D/A
| Juvenescence Ltd reports a 72.6% stake in AGEX THERAPEUTICS, INC. |
| 12/15/2022 |
SC 13D/A
| Juvenescence Ltd reports a 74.9% stake in AGEX THERAPEUTICS, INC. |
| 10/25/2022 |
SC 13D/A
| Juvenescence Ltd reports a 73.4% stake in AGEX THERAPEUTICS, INC. |
| 08/23/2022 |
SC 13D/A
| Juvenescence Ltd reports a 72.1% stake in AGEX THERAPEUTICS, INC. |
| 06/24/2022 |
SC 13D/A
| Juvenescence Ltd reports a 72.5% stake in AGEX THERAPEUTICS, INC. |
| 04/11/2022 |
SC 13D/A
| Juvenescence Ltd reports a 68.1% stake in AGEX THERAPEUTICS, INC. |
| 02/22/2022 |
SC 13D/A
| Juvenescence Ltd reports a 69.5% stake in AGEX THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13D/A
| Juvenescence Ltd reports a 64.8% stake in AGEX THERAPEUTICS, INC. |
| 12/13/2021 |
SC 13D/A
| Juvenescence Ltd reports a 67.3% stake in AGEX THERAPEUTICS, INC. |
| 11/18/2021 |
SC 13D/A
| Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC. |
| 11/02/2021 |
SC 13D/A
| Juvenescence Ltd reports a 63% stake in AGEX THERAPEUTICS, INC. |
| 09/14/2021 |
SC 13D/A
| Juvenescence Ltd reports a 60.4% stake in AGEX THERAPEUTICS, INC. |
| 05/26/2021 |
SC 13D/A
| Juvenescence Ltd reports a 57.2% stake in AGEX THERAPEUTICS, INC. |
| 05/11/2021 |
SC 13D/A
| Juvenescence Ltd reports a 56.1% stake in AGEX THERAPEUTICS, INC. |
| 02/17/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.7% stake in AGEX THERAPEUTICS, INC. |
| 02/09/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.6% stake in AGEX THERAPEUTICS, INC. |
| 01/12/2021 |
SC 13D/A
| Juvenescence Ltd reports a 52.7% stake in AGEX THERAPEUTICS, INC. |
| 11/19/2020 |
SC 13D/A
| Juvenescence Ltd reports a 50% stake in AGEX THERAPEUTICS, INC. |
| 10/07/2020 |
SC 13D/A
| Juvenescence Ltd reports a 50% stake in AGEX THERAPEUTICS, INC. |
| 07/31/2020 |
SC 13D/A
| Juvenescence Ltd has filed a Schedule 13D for AGEX THERAPEUTICS, INC. |
| 04/06/2020 |
SC 13D/A
| Juvenescence Ltd has filed a Schedule 13D for AGEX THERAPEUTICS, INC. |
| 08/16/2019 |
SC 13D
| Juvenescence Ltd has filed a Schedule 13D for AGEX THERAPEUTICS, INC. |
| 02/12/2019 |
SC 13G
| Juvenescence Ltd reports a 45.8% stake in AGEX THERAPEUTICS, INC. |